A New Frontier in Cardiovascular Prevention: Beyond Prohibition, Clinical Management of Anabolic Steroid Users
ABC Imagem Cardiovascular · 29.06.2026 · 39 (2)
DOI: 10.36660/abcimg.20260076i ↗Kurz gefasst
Fachartikel in der Zeitschrift ABC Imagem Cardiovascular, erschienen am 29.06.2026. Verfasst von Fabio Roston und 4 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Subclinical Diagnosis: The Role of Advanced Echocardiography Conventional cardiac assessment often fails to detect early damage, as Left Ventricular Ejection Fraction (LVEF) may remain within normal limits despite established myocardial injury. The literature highlights that AAS users exhibit alterations in cardiac geometry and function, including pathological hypertrophy, diastolic dysfunction, and biventricular impairment., In this setting, echocardiography incorporating advanced measurements such as myocardial strain has emerged as an essential diagnostic tool. Although LVEF may remain preserved during the early stages, myocardial [...]
Zitieren
APA
Roston, F., Ribeiro, A. A. A., Makiniks, N. C., Ribeiro, L. F. B., & Ziegler, L. L. (2026). A New Frontier in Cardiovascular Prevention: Beyond Prohibition, Clinical Management of Anabolic Steroid Users. ABC Imagem Cardiovascular, 39(2). https://doi.org/10.36660/abcimg.20260076i
Vancouver
Roston F, Ribeiro AAA, Makiniks NC, Ribeiro LFB, Ziegler LL. A New Frontier in Cardiovascular Prevention: Beyond Prohibition, Clinical Management of Anabolic Steroid Users. ABC Imagem Cardiovascular. 2026;39(2). doi:10.36660/abcimg.20260076i
BibTeX
@article{Roston2026,
author = {Roston, Fabio and Ribeiro, Alexandre Aby Azar and Makiniks, Naiara Caroline and Ribeiro, Luiz Felipe Branco and Ziegler, Liliana Ludwing},
title = {A New Frontier in Cardiovascular Prevention: Beyond Prohibition, Clinical Management of Anabolic Steroid Users},
journal = {ABC Imagem Cardiovascular},
year = {2026},
volume = {39},
number = {2},
doi = {10.36660/abcimg.20260076i}
}
EUVIMED